Citigroup’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-164,837
Closed -$9.25M 7516
2016
Q4
$9.25M Buy
164,837
+153,813
+1,395% +$7.84M 0.01% 1256
2016
Q3
$532K Buy
11,024
+6,269
+132% +$292K ﹤0.01% 3843
2016
Q2
$198K Sell
4,755
-8,138
-63% -$303K ﹤0.01% 4509
2016
Q1
$419K Buy
12,893
+11,786
+1,065% +$340K ﹤0.01% 4322
2015
Q4
$38K Buy
1,107
+4
+0.4% +$136 ﹤0.01% 6137
2015
Q3
$36K Buy
1,103
+825
+297% +$29.6K ﹤0.01% 5651
2015
Q2
$10K Buy
278
+12
+5% +$391 ﹤0.01% 6489
2015
Q1
$8K Sell
266
-2,674
-91% -$76.8K ﹤0.01% 6578
2014
Q4
$80K Buy
2,940
+2,333
+384% +$63.3K ﹤0.01% 5395
2014
Q3
$15K Buy
607
+462
+319% +$11K ﹤0.01% 6073
2014
Q2
$3K Sell
145
-2,455
-94% -$53.7K ﹤0.01% 6685
2014
Q1
$68K Sell
2,600
-2,695
-51% -$67.1K ﹤0.01% 5292
2013
Q4
$122K Buy
5,295
+4,763
+895% +$93.3K ﹤0.01% 5089
2013
Q3
$9K Buy
532
+336
+171% +$5.44K ﹤0.01% 6265
2013
Q2
$3K Buy
+196
New +$3.08K ﹤0.01% 6481

Other funds holding VASC

Citigroup's VASC Position: Q1 2017 in Review

Citigroup sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 164,837 shares — an estimated $9.25M sold.

Citigroup first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $9.25M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Citigroup reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Citigroup sold 164,837 Vascular Solutions Inc shares in Q1 2017, an estimated $9.25M.
  • Citigroup first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
  • Citigroup's Vascular Solutions Inc position peaked at $9.25M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.